“Bringing in new ideas is a currency that is highly regarded within the [pharmaceutical] companies. So we’re going to be coming in with something new and something tested. There’s going to be an appetite to be able to say, ‘let’s see this, let’s try it.’”
J. Melville “Mel” Engle, CEO, shared in a podcast that also featured Dr. Pamela Bush, SVP of Strategic Sales and Business Development.
Listen here for the full interview: